Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
7
×
life sciences
national blog main
7
×
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
national top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
boston
bristol-myers squibb
cancer
deals
drugs
eli lilly
immunotherapy
investing
loxo oncology
merck
pfizer
What
time
7
×
fda
approved
days
drug
friday
medicine
patients
acquire
add
adding
agency
ago
aimmune
airport
allergy
alliance
alnylam
annual
apocalypse
approval
approve
atrial
awaits
awarded
beds
bio
biological
boston
bristol
business
buy
called
calls
cancer
carbidopa
celgene
changing
color
combination
Language
unset
Current search:
time
×
fda
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion